Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference...

* Reuters is not responsible for the content in this press release.

Tue Sep 2, 2008 2:05pm EDT 

Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference and the Baird Small Cap Healthcare Conference

BOULDER, Colo.--(Business Wire)--
Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Robert E. Conway, will speak at the Morgan Stanley
Global Healthcare Unplugged Conference on September 9 and the Baird
Small Cap Healthcare Conference on September 10 in New York City. The
public is welcome to participate in the conferences through webcasts
on the Array BioPharma website.

-0-
*T
Event:                  Morgan Stanley Global Healthcare Unplugged
                         Conference
Presenter:              Robert E. Conway, Chief Executive Officer,
                         Array BioPharma
Date:                   Tuesday, September 9, 2008
Time:                   10:20 a.m. Eastern Time
Location:               Grand Hyatt New York, New York City
Webcast:                www.arraybiopharma.com

Event:                  Baird Small Cap Healthcare Conference
Presenter:              Robert E. Conway, Chief Executive Officer,
                         Array BioPharma
Date:                   Wednesday, September 10, 2008
Time:                   9:05 a.m. Eastern Time
Location:               InterContinental The Barclay New York, New
                         York City
Webcast:                www.arraybiopharma.com
*T

   About Array BioPharma

   Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small
molecule drugs to treat patients afflicted with cancer, inflammatory
diseases and pain. Our proprietary drug development pipeline includes
clinical candidates that are designed to regulate therapeutically
important target proteins and are aimed at significant unmet medical
needs. In addition, leading pharmaceutical and biotechnology companies
collaborate with Array to discover and develop drug candidates across
a broad range of therapeutic areas. For more information on Array,
please go to www.arraybiopharma.com.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.